CLOV earnings: real EPS beat/miss history, analyst consensus Hold, P/E -41.96. Updated 2026-07-23.
Clover Health Investments (CLOV) Research Hub
Clover Health Investments (CLOV) trades on NASDAQ, US in the Healthcare (Medical - Healthcare Plans) sector. As of 2026-09-11, shares last closed at 4.82 USD (+11.06%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -41.96, market cap 2.47B. This hub links to the full technical, earnings and options research available for CLOV.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Healthcare Plans) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.82 USD (+11.06%) |
| 52-week range | 4.04 USD – 5.51 USD |
| Trend regime | Range |
| 14-day RSI | 51.8 (Neutral) |
| Trailing P/E | -41.96 |
| Market cap | 2.47B |
| Dividend yield | 0.00% |
Available research for CLOV
Covered Call on CLOV: how it works, illustrative setup around the real 4.82 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CLOV: how it works, illustrative setup around the real 4.82 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CLOV: how it works, illustrative setup around the real 4.82 USD price, max profit/loss, breakeven and when to use it. Educational.
CLOV technical analysis: range, last 4.82 USD, RSI 51.8, 52w range 4.04 USD–5.51 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CLOV in?
Clover Health Investments (CLOV) is classified under Healthcare (Medical - Healthcare Plans), listed on NASDAQ, US.
Is CLOV in an uptrend or downtrend?
As of 2026-09-11, CLOV is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CLOV's trailing P/E ratio?
CLOV's trailing P/E is -41.96, with a market cap of 2.47B. See the earnings research page for full valuation detail.